REPCF REPLICEL LIFE SCIENCES INC
- 0.002000
- -0.000100-4.76%
REPLICEL LIFE SCIENCES INC News
REPLICEL LIFE SCIENCES INC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Andrew Schutte(34.53%)
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew Schutte(31.17%)
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew Schutte(16.41%)
REPLICEL LIFE SCIENCES INC | SC 13D: Statement of acquisition of beneficial ownership by individuals-Andrew Schutte(15.22%)
REPLICEL LIFE SCIENCES INC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew Schutte(18.55%)
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | D/A: Filing D (Amendment)
REPLICEL LIFE SCIENCES INC | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | D: Filing D
Analysis
Price Target
No Data
No Data